Inthera Bioscience

Switzerland
Schlieren, Zurich, Switzerland, 8952

Company profile

Inthera Bioscience company profile

Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
8952
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$20.1M
Last funding
Series A / $5.5M / 2018-06-26
Last equity funding
Series A / $5.5M
Investors
5
Lead investors
3
Founders
1
Articles
4

Founders and investors

Founders

Ulrich Kessler

Lead investors

Aglaia BioMedical VenturesM VenturesNovo Holdings

Investors

Aglaia BioMedical VenturesEVA BaselMicrosoft AcceleratorM VenturesNovo Holdings